Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia [Phase 2]
Phase 2 clinical trial evaluating azacitidine and lenalidomide in relapsed/refractory acute myeloid leukemia has completed with results post…
-
CLINICAL_TRIALS trial_result · 2019-10-07Clinical Trial Update: Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia [Phase 2]
Phase 2 trial of clofarabine with cytarabine in patients with minimal residual disease-positive acute leukemia was terminated; results poste…
-
CLINICAL_TRIALS trial_result · 2019-09-24Clinical Trial Update: Lirilumab and Azacitidine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating lirilumab with azacitidine in refractory or relapsed acute myeloid leukemia was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-24Clinical Trial Update: Omacetaxine for Consolidation and Maintenance [Phase 2]
Phase 2 clinical trial of omacetaxine for consolidation and maintenance in acute myeloid leukemia has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies [Phase 1, Phase 2]
A multi-CAR T therapy targeting CD7 is being studied in Phase 1/Phase 2 for CD7-positive malignancies including T-cell acute lymphoblastic l…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications [Phase 1, Phase 2]
A dose-escalation Phase I study is evaluating safety and preliminary activity of a multi-indication cancer therapy in acute myeloid leukemia…
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia [Phase 3]
Phase 3 trial comparing caspofungin to fluconazole for preventing invasive fungal infections in patients undergoing chemotherapy for acute m…
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients [Phase 3]
Phase 3 trial evaluating DAC combined with the HAAG regimen in newly diagnosed younger patients with acute myeloid leukemia undergoing induc…
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Trial of Daily Pulse Interleukin-2 With Famotidine in Acute Myelogenous Leukemia [Phase 2]
Phase 2 trial of daily pulse interleukin-2 with famotidine in acute myeloid leukemia was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML [Phase 3]
Phase 3 trial comparing nonmyeloablative host conditioning with TLI & ATG to standard of care in acute myeloid leukemia; study terminated wi…
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60 [Phase 3]
APhase 3 trial evaluating DAC plus HAAG regimen for newly diagnosed AML patients over 60 years old; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 2]
Phase 2 trial evaluating the WEE1 inhibitor AZD1775 with or without cytarabine in advanced acute myeloid leukemia or myelodysplastic syndrom…
-
CLINICAL_TRIALS trial_result · 2019-08-26Clinical Trial Update: Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML [Phase 2, Phase 3]
Clinical trial evaluating sorafenib to prevent leukemia relapse after allogeneic stem cell transplantation in FLT3-ITD positive AML; complet…
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating a cladribine-based combination (CAG) in patients with refractory/relapsed acute myeloid leukemia; status is current…
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation [Phase 2]
Phase 2 clinical trial investigating midostaurin plus decitabine in older adults with newly diagnosed AML and FLT3 mutation; study status te…
-
CLINICAL_TRIALS trial_result · 2019-08-01Clinical Trial Update: Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
Phase 2 trial of vincristine sulfate liposome for relapsed or refractory acute myeloid leukemia has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: Decitabine Combined With Unrelated Cord Blood Transplantation for Elderly Patients With AML [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating decitabine with unrelated cord blood transplantation in elderly patients with acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Hematologic Malignancies (MK-8628-005) [Phase 1]
Phase 1 dose-exploration trial of Birabresib (MK-8628) in selected hematologic malignancies (AML variants and DLBCL) has been terminated wit…
-
CLINICAL_TRIALS trial_result · 2019-07-16Clinical Trial Update: A Clinical Study of SKLB1028 Capsule in the Treatment of Recurrence/Refractory AML Patients [Phase 2]
Phase 2 clinical trial update for SKLB1028 Capsule in recurrence/refractory acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2019-07-16Clinical Trial Update: Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) [Phase 1, Phase 2]
A clinical trial update for sapacitabine in acute myeloid leukemia and myelodysplastic syndromes (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: A Study of Active Immunotherapy With GRNVAC1 in Patients With Acute Myelogenous Leukemia (AML) [Phase 2]
Phase 2 clinical trial update for GRNVAC1 active immunotherapy in acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2019-06-28Clinical Trial Update: A Phase I Dose Escalation Study of GSK2879552 in Subjects With Acute Myeloid Leukemia (AML) [Phase 1]
Phase I dose-escalation study of GSK2879552 in subjects with acute myeloid leukemia was terminated early; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-06-26Clinical Trial Update: Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes [Phase 1, Phase 2]
Phase 1/2 trial evaluating a combination including filgrastim, cladribine, cytarabine, and mitoxantrone in newly diagnosed or relapsed/refra…
-
CLINICAL_TRIALS trial_result · 2019-06-17Clinical Trial Update: A Study of Decitabine (DACOGEN) in Sequential Administration With Cytarabine in Children With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]
Phase 1/2 trial evaluating sequential decitabine with cytarabine in children with relapsed or refractory acute myeloid leukemia; study termi…
-
CLINICAL_TRIALS trial_result · 2019-06-11Clinical Trial Update: A Study of LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
Phase 2 trial update for LY2181308 Sodium in relapsed or refractory acute myeloid leukemia has completed with results posted.